Skip to main content

Wengen Chen, BM, PhD, MSc

Academic Title:

Associate Professor

Primary Appointment:

Diagnostic Radiology and Nuclear Medicine

Location:

UMMC, Gudelski, C252

Phone (Primary):

866-408-6885

Education and Training

BM, Shanghai Medical University (now Fudan University), China

MPH, Shanghai Medical University (now Fudan University), China

PhD,  University of Tokyo, Japan

Postdoc., Columbia University, NY

Internship in Internal Medicine,  St. University Hospital, New Brunswick, NJ

Residency in Nuclear Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA

Fellowship in Nuclear Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA

Biosketch

I received my medical degree from China, and my Ph.D from Japan. I have more than a decade of basic science research experiences in molecular biology of lipid metabolism and atherosclerosis. After finishing my postdoctoral training at Columbia University, I restarted my clinical training, as a nuclear medicine resident and fellow, from the hospital of the University of Pennsylvania. I stated my current position in 2009 as an assistant professor, and was promoted to associate profession in 2014. I am a full-time board certified nuclear medicine physician, and provide services in general nuclear medicine imaging, PET/CT cancer imaging, and radionuclide therapy.

Research/Clinical Keywords

PET/CT, atherosclerosis, infection

Highlighted Publications

Cao Q, Hersl J, La H, Smith M, Jenkins J, Goloubeva O, Dilsizian V, Tkaczuk K, Chen W (corresponding author), Jones L. A pilot study of FDG PET/CT detects a link between brown adipose tissue and breast cancer. BMC Cancer. 2014, 14:126-131.

Kim J, Feller ED, Chen W, Dilsizian V. FDG PET/CT Imaging for LVAD Associated Infections. JACC Cardiovasc Imaging. 2014, 7:839-42.

Chen W, Dilsizian V. PET assessment of vascular inflammation and atherosclerotic plaques: SUV or TBR? J Nucl Med. 2015, 56:502-4.

Research Interests

New PET tracers for imaging atherosclerosis and infection

Clinical Specialty Details

Nuclear Medicine and PET/CT

 

Provide services of General Nuclear Medicine imaging, PET/CT cancer imaging, Cardiac Stress Perfusion, and radionuclide therapy

including I-131 for thyroid disoeders, radioimunotherapy for non-Hodgkin’s lymphoma, radionuclides for bone pain

palliation and Xofigo (Radium-223) for prostate cancer bone metastases.

Awards and Affiliations

Travel Grant Award, 34th ACNM annual meeting

Honorable Mention of the Siemens Award for Excellence in Practice Based Research, 55th SNMMI annual meeting

Teaching Award, Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine

Science Council Research Symposium Oral Presentation and the Best in Physics Poster, American Association of Physicists in Medicine Annual Meeting

First Place Poster - Clinical Diagnosis Track, 59th SNMMI Annual Meeting

Elite Reviewer, JACC, Journal of the American College of Cardiology

Third Place Poster - Oncology: Clinical Diagnosis Track, 60th SNMMI Annual Meeting

SNMMI Future Leaders Academy

FACNM, fellow of American College of Nuclear Medicine

In the News

Active Grant:

07/01/2013-06/30/2017, Co-Investigator (6.4% effort), R01CA172638, NIH/NCI, (PI: Dr. Wei Lu, Department of Radiation Oncology, UMB)

Quantitative PET/CT Analysis to Improve Evaluation of Tumor Response

Role: to assist Dr. Lu in project design, provide extensive PET/CT imaging interpretation, review/perform image registration and tumor segmentation, and evaluate the clinical significance of the results. 

                                        

08/01/2014-07/31/2017,    Co-Investigator (2% effort), Maryland Industrial Partnerships (MIPS), (PI: Dr. Mark Smith, Department of Diagnostic Radiology and Nuclear Medicine, UMB)

Brain Imaging Device with Motion Compensation

Role: to assist Dr. Smith in project design, provide brain PET/CT interpretation, data analysis and evaluate the clinical significance. 

 

07/01/2016-06/30/2020,    Co-Investigator (2% effort), R01CA172638, NIH/NCI, (PI: Dr. Amit Sawant, Department of Radiation Oncology, UMB)

Investigating Radiation-Induced Injury to Airways and Pulmonary Vasculature in Lung Stereotactic Ablative Body Radiotherapy (SAbR)

Role: to provide extensive V/Q scan and SPECT imaging interpretation, and evaluate the clinical significance of the results. 

                                         

Completed Grant:

09/01/2012-08/30/2013     Principal Investigator ,UMB/UMD seed fund

18F-Proline PET/CT Imaging for the Detection of Early Liver Fibrosis

 

07/01/2007-06/30/2008     Principal Investigator, Pilot Research Grant in Molecular Imaging, SNMMI

Glucose metabolism in macrophage foam cells: Molecular mechanism for FDG-PET imaging of atherosclerosis

Professional Activity

2011-present   Abstract Review Panel (Endocrinology and Neuroendocrine tumor sections), SNMMI Annual Meeting Scientific Program Committee

2014-present   Committee Member, Membership Task Force, SNMMI

2014-2016       Executive Committee, Mid-Eastern Chapter, SNMMI

2015-present   Board of Directors, Cardiovascular Council, SNMMI

2016-present   Treasure, Mid-Eastern Chapter, SNMMI

2016-present   Board of Directors, American Board of Nuclear Medicine